The drug, which was being tested in humans for the first time, was used to treat breast, bowel and prostate tumours at the Royal Marsden NHS Foundation Trust. It stopped tumour growth in eight out of 21 patients who received it and shrunk the tumours of ...
from Google Alert - health https://ift.tt/36giGVW
via IFTTT
0 comments:
Post a Comment